<table id="tablei" width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.<footnote id="table1a">For various North American patient populations from literature reports. Different rates of elimination and consequent dosage requirements have been observed among other peoples.</footnote>
</caption>
<col align="left" valign="top" width="50%"></col>
<col align="left" valign="top" width="30%"></col>
<col align="left" valign="top" width="20%"></col>
<thead>
<tr>
<th valign="bottom">Population characteristics</th>
<th align="center">Total body clearance<footnote id="table1b">Clearance represents the volume of blood completely cleared of theophylline by the liver in one minute.  Values listed were generally determined at serum theophylline concentrations &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum concentrations due to non-linear pharmacokinetics. </footnote>
<br/>mean (range) <footnote id="table1c">Reported range or estimated range (mean ± 2 SD) where actual range not reported.</footnote>
<br/>(mL/kg/min) </th>
<th align="center">Half-life Mean (range) <footnoteref idref="table1c"></footnoteref>
<br/>(hr)</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="3">
<content stylecode="bold underline">Note:</content>  In addition to the factors listed above, theophylline clearance is increased and half-life decreased by low carbohydrate/high protein diets, parenteral nutrition, and daily consumption of charcoal-broiled beef. A high carbohydrate/low protein diet can decrease the clearance and prolong the half-life of theophylline.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>
<content stylecode="bold underline">Age</content>
</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Premature neonates</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  postnatal age 3-15 days</td>
<td>0.29 (0.09-0.49)</td>
<td>30 (17-43)</td>
</tr>
<tr>
<td>  postnatal age 25-57 days</td>
<td>0.64 (0.04-1.2)</td>
<td>20 (9.4-30.6)</td>
</tr>
<tr>
<td>Term infants</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  postnatal age 1-2 days</td>
<td>NR <footnote id="table1d">NR =not reported or not reported in a comparable format.</footnote>
</td>
<td>25.7 (25-26.5)</td>
</tr>
<tr>
<td>  postnatal age 3-30 weeks</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
<td>11 (6-29)</td>
</tr>
<tr>
<td>Children</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  1-4 years</td>
<td>1.7 (0.5-2.9)</td>
<td>3.4 (1.2-5.6)</td>
</tr>
<tr>
<td>  4-12 years</td>
<td>1.6 (0.8-2.4)</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
</tr>
<tr>
<td>  13-15 years</td>
<td>0.9 (0.48-1.3)</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
</tr>
<tr>
<td>  6-17 years</td>
<td>1.4 (0.2-2.6)</td>
<td>3.7 (1.5-5.9)</td>
</tr>
<tr>
<td>Adults (16-60 years)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  otherwise healthy non-smoking asthmatics</td>
<td>0.65 (0.27-1.03)</td>
<td>8.7 (6.1-12.8)</td>
</tr>
<tr>
<td>Elderly (&gt;60 years)	</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  non-smokers with normal cardiac, liver, and renal function</td>
<td valign="bottom">0.41 (0.21-0.61)</td>
<td valign="bottom">9.8 (1.6-18)</td>
</tr>
<tr>
<td colspan="3">
<content stylecode="bold underline">Concurrent illness or altered physiological state</content>
</td>
</tr>
<tr>
<td>Acute pulmonary edema</td>
<td>0.33<footnote id="table1e">Median</footnote> (0.07-2.45)</td>
<td>19<footnoteref idref="table1e"></footnoteref> (3.1-82)</td>
</tr>
<tr>
<td>COPD &gt;60 years, stable	</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  non-smoker &gt;1 year</td>
<td>0.54 (0.44-0.64)</td>
<td>11 (9.4-12.6)</td>
</tr>
<tr>
<td>COPD with cor-pulmonale</td>
<td>0.48 (0.08-0.88)</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
</tr>
<tr>
<td>Cystic fibrosis (14-28 years)</td>
<td>1.25 (0.31-2.2)</td>
<td>6.0 (1.8-10.2)</td>
</tr>
<tr>
<td>Fever associated with acute viral</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  respiratory illness (children 9-15 years)</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
<td>7.0 (1.0-13)</td>
</tr>
<tr>
<td>Liver disease – cirrhosis</td>
<td>0.31<footnoteref idref="table1e"></footnoteref> (0.1-0.7)</td>
<td>32<footnoteref idref="table1e"></footnoteref> (10-56)</td>
</tr>
<tr>
<td align="left">                       acute hepatitis</td>
<td>0.35 (0.25-0.45)</td>
<td>19.2 (16.6-21.8)</td>
</tr>
<tr>
<td align="left">                       cholestasis</td>
<td>0.65 (0.25-1.45)</td>
<td>14.4 (5.7-31.8)</td>
</tr>
<tr>
<td>Pregnancy – 1<sup>st</sup> trimester</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
<td>8.5 (3.1-13.9)</td>
</tr>
<tr>
<td align="left">                   2<sup>nd</sup> trimester</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
<td>8.8 (3.8-13.8)</td>
</tr>
<tr>
<td align="left">                   3<sup>rd</sup> trimester</td>
<td>NR <footnoteref idref="table1d"></footnoteref>
</td>
<td>13.0 (8.4-17.6)</td>
</tr>
<tr>
<td>Sepsis with multi-organ failure</td>
<td>0.47 (0.19-1.9)</td>
<td>18.8 (6.3-24.1)</td>
</tr>
<tr>
<td>Thyroid disease – hypothyroid</td>
<td>0.38 (0.13-0.57)</td>
<td>11.6 (8.2-25)</td>
</tr>
<tr>
<td align="left">                      hyperthyroid</td>
<td>0.8 (0.68-0.97)</td>
<td>4.5 (3.7-5.6)</td>
</tr>
</tbody>
</table>